APTS trial results have been published here. A summary of the results for APTS parents can be found here.

See ANZCTR for full trial details >

 

Trial Summary:

The Australian Placental Transfusion Study (APTS) group has conducted the largest ever randomised controlled trial of placental transfusion in very preterm babies. The study enrolled patients from 25 hospitals in seven countries around the world. The trial aimed to determine whether giving a placental transfusion at birth, by deferring clamping and cutting the cord at resuscitation improves systemic blood flow and ischaemia-reperfusion injury to brain and gut and reduces exposure to donor blood, and thus reduces sepsis, retinopathy, poor growth, mortality, morbidity and disability, in 1600 babies born at less than 30 weeks' gestation.

Supported By:

NHMRC 

Eligibility:

Infants born at less than 30 weeks' gestation.

Registration ID:

ACTRN12610000633088

Participation:

A target of 1600 babies born less than 30 weeks' gestation.

Australian Lead Group:

NHMRC CTC

Status:

Follow-up

Activation Date:

24/09/2010

Chairs:

Prof William Tarnow-Mordi & Prof Jonathan Morris

Contact:

apts@ctc.usyd.edu.au